Driven by innovation, research, and a deep commitment to social responsibility, Pharmalat has grown from a small, family-run ...

New Jersey's powerful pharmaceutical industry, already under pressure to rein in prices, is facing new headwinds from a Trump ...

American biggies are joining hands with Chinese companies. AbbVie signed a deal with Simcere Zaiming for a multiple myeloma ...

Chinese drug maker Akeso, whose new cancer drug has outperformed a leading Western peer in clinical studies, is being hailed ...

Offering free solutions can generate goodwill and strengthen relationships with both existing and potential customers. When a ...

In this article, we will be taking a look at the 15 best biotech stocks to buy according to billionaires. Although biotech ...

There are few signs the industry responsible for more than 115,000 Massachusetts jobs is pulling out of its four-year downswing.

Biotech workers can build resilience into a career full of transitions by finding matching niches and evolving skills through ...

The U.K. government is proposing to raise the rebate rate under a national drug cost program, drawing complaints from the ...

This link in the pharma supply chain is undergoing a major transformation propelled by technological advancements, regulatory ...

For the biotech industry, 2024 meant the return of the venture capital megaround. | This week on "The Top Line," we dig into ...

Leen Kawas, a biotech industry professional with decades of experience, highlights ways in which a diverse workforce ...